Light therapy is emerging as a promising, non-pharmacological treatment for Alzheimer’s disease, offering significant improvements in sleep and psycho-behavioral symptoms such as depression and ...

A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Therapy has long been about the delicate dance of self-understanding—therapists attuning to the unsaid, guiding clients ...

In a small cohort of adults in South Korea, the presence of cerebral small vessel disease was associated with color reading ...

A significant advancement in knowledge of the link between cognition and genetics has been made thanks to a study led by ...

It is inevitable that our brains shrink as we grow older. However, with healthy habits, age-related cognitive changes can be ...

CBT-E is a promising treatment for adolescents with eating disorders who did not fully recover from FBT or could not engage ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

Tisento Therapeutics has dosed the first subject in its Phase IIb PRIZM study, examining the effects of the oral ...

The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...